Dissented revised bill of pharmaceutical affairs law to reject its pass.

In the parliamentary audit from Nov. 6 to 7, the Health and Welfare Committee of the National Assembly sharply criticized the government's immatured medical reform programs and strongly urged to extract a people's consensus.

The Committee pointed out that 1) any revised draft of the pharmaceutical affairs law covering the government's medical reform program would never be passed through unle...